News & Updates

Patients with early-stage cervical usual-type adenocarcinoma and adenosquamous carcinoma who undergo minimally invasive radical hysterectomy (RH) appear to have comparable survival outcomes as their counterparts who receive open RH, according to a study.

New drug applications approved by US FDA as of 01 - 15 August 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

A large number of cancer survivors and patients fear disease recurrence, reports a recent meta-analysis. Healthcare providers should address this issue with their patients and be ready to recommend interventions when needed.

Men take into consideration both personal and medical factors when deciding to continue active surveillance, reports a recent study.

In childhood cancer survivors (CCS), treatment with vincristine appears to be linked with global longitudinal strain (GLS) abnormalities over the long-term, a new study has found.